Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP).
Wien Klin Wochenschr
; 132(13-14): 365-386, 2020 Jul.
Article
em En
| MEDLINE
| ID: mdl-32533443
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Pneumologia
/
Infecções por Coronavirus
/
Coronavirus
/
Pandemias
/
Pneumopatias
Tipo de estudo:
Diagnostic_studies
/
Guideline
Limite:
Adolescent
/
Adult
/
Child
/
Humans
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article